Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET

被引:0
|
作者
Park, Yong-Jin [1 ]
Moon, So Young [2 ]
Yoon, Joon-Kee [1 ]
Lee, Su-Jin [1 ]
An, Young-Sil [1 ,3 ]
机构
[1] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Neurol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Nucl Med & Mol Imaging, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea
来源
EJNMMI RESEARCH | 2025年 / 15卷 / 01期
关键词
Amyloid; Positron emission tomography; Flutemetamol; Cutoff; CortexID suite; VALIDATION;
D O I
10.1186/s13550-024-01193-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background This study aimed to establish the optimal cutoff values for visual amyloid positivity using standardized uptake value ratios (SUVRs) in [F-18]flutemetamol (FMM) positron emission tomography (PET) imaging. Given the variability in amyloid assessment, our goal was to determine cutoff values that enhance diagnostic accuracy and assist clinicians in reliably identifying amyloid positivity. Results The identified cutoff values for visual amyloid positivity were > 1.6 for the cerebellar gray matter, > 1.38 for the whole cerebellum, and > 0.63 for the pons, yielding high sensitivity (95.5%, 94.5%, and 95.8%, respectively) and specificity (91.2%, 94.3%, and 95.2%, respectively). Conclusions The SUVR cutoff values demonstrated excellent diagnostic performance, supporting their clinical use in assessing visual amyloid positivity in [F-18]FMM PET imaging.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
    Marissa D. Zwan
    Femke H. Bouwman
    Elles Konijnenberg
    Wiesje M. van der Flier
    Adriaan A. Lammertsma
    Frans R. J. Verhey
    Pauline Aalten
    Bart N. M. van Berckel
    Philip Scheltens
    Alzheimer's Research & Therapy, 9
  • [12] Diagnostic impact of [18F] flutemetamol PET in early-onset dementia
    Zwan, Marissa D.
    Bouwman, Femke H.
    Konijnenberg, Elles
    van der Flier, Wiesje M.
    Lammertsma, Adriaan A.
    Verhey, Frans R. J.
    Aalten, Pauline
    van Berckel, Bart N. M.
    Scheltens, Philip
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [13] Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
    Ikonomovic, Milos D.
    Buckley, Chris J.
    Heurling, Kerstin
    Sherwin, Paul
    Jones, Paul A.
    Zanette, Michelle
    Mathis, Chester A.
    Klunk, William E.
    Chakrabarty, Aruna
    Ironside, James
    Ismail, Azzam
    Smith, Colin
    Thal, Dietmar R.
    Beach, Thomas G.
    Farrar, Gill
    Smith, Adrian P. L.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 130
  • [14] A deep learning model for generating [18F]FDG PET Images from early-phase [18F]Florbetapir and [18F]Flutemetamol PET images
    Sanaat, Amirhossein
    Boccalini, Cecilia
    Mathoux, Gregory
    Perani, Daniela
    Frisoni, Giovanni B.
    Haller, Sven
    Montandon, Marie-Louise
    Rodriguez, Cristelle
    Giannakopoulos, Panteleimon
    Garibotto, Valentina
    Zaidi, Habib
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (12) : 3518 - 3531
  • [15] Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology
    Beach, Thomas G.
    Thal, Dietmar Rudolf
    Zanette, Michelle
    Smith, Adrian
    Buckley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 (03) : 863 - 873
  • [16] Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
    Fiona Heeman
    Maqsood Yaqub
    Isadora Lopes Alves
    Kerstin Heurling
    Johannes Berkhof
    Juan Domingo Gispert
    Santiago Bullich
    Christopher Foley
    Adriaan A. Lammertsma
    EJNMMI Research, 9
  • [17] An exploratory efficacy study of the amyloid imaging agent [18F]flutemetamol in Japanese Subjects
    Michio Senda
    Yasuji Yamamoto
    Masahiro Sasaki
    Tomohiko Yamane
    David J. Brooks
    Gill Farrar
    Brian McParland
    Kerstin Heurling
    Annals of Nuclear Medicine, 2015, 29 : 391 - 399
  • [18] Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
    Ikonomovic, Milos D.
    Fantoni, Enrico R.
    Farrar, Gill
    Salloway, Stephen
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [19] An exploratory efficacy study of the amyloid imaging agent [18F]flutemetamol in Japanese Subjects
    Senda, Michio
    Yamamoto, Yasuji
    Sasaki, Masahiro
    Yamane, Tomohiko
    Brooks, David J.
    Farrar, Gill
    McParland, Brian
    Heurling, Kerstin
    ANNALS OF NUCLEAR MEDICINE, 2015, 29 (05) : 391 - 399
  • [20] Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
    Milos D. Ikonomovic
    Chris J. Buckley
    Kerstin Heurling
    Paul Sherwin
    Paul A. Jones
    Michelle Zanette
    Chester A. Mathis
    William E. Klunk
    Aruna Chakrabarty
    James Ironside
    Azzam Ismail
    Colin Smith
    Dietmar R. Thal
    Thomas G. Beach
    Gill Farrar
    Adrian P. L. Smith
    Acta Neuropathologica Communications, 4